180 related articles for article (PubMed ID: 31926052)
1. Estimated birth prevalence of mucopolysaccharidoses in Brazil.
Federhen A; Pasqualim G; de Freitas TF; Gonzalez EA; Trapp F; Matte U; Giugliani R
Am J Med Genet A; 2020 Mar; 182(3):469-483. PubMed ID: 31926052
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of mucopolysaccharidoses.
Khan SA; Peracha H; Ballhausen D; Wiesbauer A; Rohrbach M; Gautschi M; Mason RW; Giugliani R; Suzuki Y; Orii KE; Orii T; Tomatsu S
Mol Genet Metab; 2017 Jul; 121(3):227-240. PubMed ID: 28595941
[TBL] [Abstract][Full Text] [Related]
3. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
[TBL] [Abstract][Full Text] [Related]
4. The frequency of common mutations among patients with mucopolysaccharidosis types I, II and IIIA diagnosed in Austria over the last 17 years.
Kroepfl T; Milos I; Paul K; Plecko B; Paschke E
Clin Genet; 2001 Nov; 60(5):393-4. PubMed ID: 11903343
[No Abstract] [Full Text] [Related]
5. Incidence of the mucopolysaccharidoses in Northern Ireland.
Nelson J
Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidoses and mucolipidoses.
Van Hoof F
J Clin Pathol Suppl (R Coll Pathol); 1974; 8():64-93. PubMed ID: 4220223
[No Abstract] [Full Text] [Related]
8. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
[TBL] [Abstract][Full Text] [Related]
10. Worldwide distribution of common IDUA pathogenic variants.
Poletto E; Pasqualim G; Giugliani R; Matte U; Baldo G
Clin Genet; 2018 Jul; 94(1):95-102. PubMed ID: 29393969
[TBL] [Abstract][Full Text] [Related]
11. Prevalence rates of mucopolysaccharidoses in Poland.
Jurecka A; Ługowska A; Golda A; Czartoryska B; Tylki-Szymańska A
J Appl Genet; 2015 May; 56(2):205-10. PubMed ID: 25472774
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a large cohort of mucopolysaccharidosis patients: Iran Mucopolysaccharidosis RE-diagnosis study (IMPRESsion).
Ghaffari SR; Rafati M; Shadnoush M; Pourbabaee S; Aghighi M; Mirab Samiee S; Kermanchi J; Alaei MR; Salehpour S; Amirkashani D; Setoodeh A; Sarkhail P; Badv RS; Aminzadeh M; Shiva S; Eshraghi P; Moravej H; Hashemipour M; Rostampour N; Hamidieh AA; Shamsian BS; Shams S; Zamanfar D; Ebrahimi A; Otadi A; Tara SZ; Barati Z; Fakhri L; Hoseini A; Amiri H; Ramandi S; Mostofinezhad N; Kani ZP; Mohammadyari E; Khosravi M; Saadati M; Hoseininasab F; Khorram Khorshid HR; Modaberisaber Y
Hum Mutat; 2022 Apr; 43(4):e1-e23. PubMed ID: 35005816
[TBL] [Abstract][Full Text] [Related]
13. Mucopolysaccharidoses: ultrastructure of leukocyte inclusions.
Markesbery WR; Robinson RO; Falace PV; Frye MD
Ann Neurol; 1980 Sep; 8(3):332-6. PubMed ID: 6776876
[TBL] [Abstract][Full Text] [Related]
14. The live-birth prevalence of mucopolysaccharidoses in Estonia.
Krabbi K; Joost K; Zordania R; Talvik I; Rein R; Huijmans JG; Verheijen FV; Õunap K
Genet Test Mol Biomarkers; 2012 Aug; 16(8):846-9. PubMed ID: 22480138
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.
Moreira GA; Kyosen SO; Patti CL; Martins AM; Tufik S
Sleep Breath; 2014 Dec; 18(4):791-7. PubMed ID: 24705807
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities.
Puckett Y; Mallorga-Hernández A; Montaño AM
Orphanet J Rare Dis; 2021 May; 16(1):241. PubMed ID: 34051828
[TBL] [Abstract][Full Text] [Related]
18. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis].
Malm G; Bondeson ML; von Döbeln U; Månsson JE
Lakartidningen; 2002 Apr; 99(16):1804-9. PubMed ID: 12043480
[TBL] [Abstract][Full Text] [Related]
19. Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-L-iduronidase.
Mandelli J; Wajner A; Pires R; Giugliani R; Coelho JC
Clin Chim Acta; 2001 Oct; 312(1-2):81-6. PubMed ID: 11580912
[TBL] [Abstract][Full Text] [Related]
20. Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes.
Borges P; Pasqualim G; Giugliani R; Vairo F; Matte U
Orphanet J Rare Dis; 2020 Nov; 15(1):324. PubMed ID: 33208168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
